PATENT CLAIM ANALYSIS

Application Number: 15763812
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["544", "332000"]

Abstract:
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, stereoisomer or prodrug thereof, wherein R 1 , R 3a , R 3b , R 4a , R 4b , G 1 , G 2 , G 2 , G 3 , G 4 , m 1 , m 2 , m 3 , m 4 , L 1 , L 2  and E are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of G12C mutant KRAS protein for treatment of disorders, such as cancer, are also provided.

Claim (Index 12):
The compound of any one of  claims 1 - 11 , wherein R 2c  has one of the following structures:

Metadata:
- Claim Count in Document: 105.0
- Percentile: 90.0
- Lexical Diversity: 1.9403
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15764088', '15093951', '15566648', '15916075', '15217304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8430350880801908
- 35 USC 102 Novelty (BERT): 0.5955866904321995
- Combined Prediction Score: 0.8182902483153917
- Mean Citation Score: 572.177954
- Max Citation Score: 582.53613
- Similarity Product: 423.9144208264464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test